SCHEMBL19662760

SCHEMBL19662760

Cc1cccc(C(=O)Nc2ccc3c(cnn3C)c2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.64
▸ RAB9A P51151 5/20 0.64
▸ MAOB P27338 3/20 0.64
▸ MAOA P21397 2/20 0.64
▸ ACHE P22303 1/20 0.64
▸ ALDH1A1 P00352 1/20 0.61
▸ MAPT P10636 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ ALOX12 P18054 1/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ MEN1 O00255 3/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ KCNK3 O14649 6/20 0.58
▸ KCNK9 Q9NPC2 5/20 0.58
▸ KCNH2 Q12809 1/20 0.58
▸ MAPK10 P53779 2/20 0.57
▸ MAPK8 P45983 1/20 0.56
▸ RXFP1 Q9HBX9 1/20 0.55
▸ POLB P06746 1/20 0.54
▸ TP53 P04637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19662769 0.90 KMT2A (0.61) NPC1RAB9AMAOBMAOAACHE
SCHEMBL29510910 0.87 NPC1 (0.78) NPC1RAB9AMAOBMAOAACHE
SCHEMBL24367775 0.85 MAOB (0.64) NPC1RAB9AMAOBMAOAACHE
SCHEMBL21237220 0.85 MAOB (0.60) NPC1RAB9AMAOBMAOAACHE
SCHEMBL16686040 0.80 NPC1 (0.63) NPC1RAB9AMAOBMAOAACHE
SCHEMBL15875716 0.78 MAOB (1.00) NPC1RAB9AMAOBMAOAACHE
SCHEMBL15874997 0.78 MAOB (1.00) NPC1RAB9AMAOBMAOAACHE
SCHEMBL19662795 0.77 MAOB (0.54) NPC1RAB9AMAOBMAOAACHE
SCHEMBL1167819 0.76 F2 (0.50) NPC1RAB9AALDH1A1MAPTHPGD
SCHEMBL19662804 0.76 KDM1A (0.65) NPC1RAB9AKMT2AMEN1KCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 — — EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 — — WO disclosed
Send feedback